IN8bio raises $14.4M in private placement; potential total up to $46.9M via warrant exercises

IN8BIO, INC.

Initial gross proceeds of $14.4M from selling 11.8M units at $1.22/unit; extends cash runway into 2025.
Investors get Series A warrants ($1.25 strike) exercisable upon INB-100 11-month data announcement for up to $14.8M additional.
Series B warrants ($1.50 strike) redeemable upon 22-month data; potential $17.7M extra if all exercised.
Pre-funded warrants at $0.0001 exercise price included; Cantor Fitzgerald acted as sole placement agent.
Proceeds to fund clinical development of gamma-delta T cell therapies and general corporate purposes.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

IN8BIO, INC. entered into Securities Purchase Agreement with the purchasers named therein (the Investors) valued at $14.4 million (effective 2023-12-11).

Action: entry
Agreement: equity purchase
Counterparty: the purchasers named therein (the Investors)
Value: $14.4 million
Effective: 2023-12-11

Exact text from the filing

On December 11, 2023, IN8bio, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the purchasers named therein (the “Investors”), pursuant to which the Company agreed to issue and sell an aggregate of 11,823,829 units (the “Units”)

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

IN8BIO, INC. entered into Registration Rights Agreement with the Investors (effective 2023-12-11).

Action: entry
Counterparty: the Investors
Effective: 2023-12-11

Exact text from the filing

Also on December 11, 2023, the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with the Investors, pursuant to which the Company agreed to register for resale the Shares and the Common Stock underlying the Warrants

View on SEC.gov

197 material agreements filed in the last 30 days. Browse all material agreements →

IN8BIO, INC. filing history →

Source: SEC EDGAR

accession 0001193125-23-292706

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.